These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29538047)

  • 1. Pharmacological cognitive enhancement in pediatrics.
    Colaneri N; Sheldon M; Adesman A
    Curr Opin Pediatr; 2018 Jun; 30(3):430-437. PubMed ID: 29538047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician practices to prevent ADHD stimulant diversion and misuse.
    Colaneri N; Keim S; Adesman A
    J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance enhancing drugs in sports and the role of doctors: are there guidelines?
    Prakash K
    Indian J Med Ethics; 2013; 10(2):115-7. PubMed ID: 23697492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive enhancement in children and adolescents: is it in their best interests?
    Gaucher N; Payot A; Racine E
    Acta Paediatr; 2013 Dec; 102(12):1118-24. PubMed ID: 24033708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry relationships with physicians under scrutiny.
    Beller GA
    J Nucl Cardiol; 2008; 15(6):737-8. PubMed ID: 18984446
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.
    Graf WD; Nagel SK; Epstein LG; Miller G; Nass R; Larriviere D
    Neurology; 2013 Mar; 80(13):1251-60. PubMed ID: 23486879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice patterns and guideline adherence in the management of attention deficit/hyperactivity disorder.
    McElligott JT; Lemay JR; O'Brien ES; Roland VA; Basco WT; Roberts JR
    Clin Pediatr (Phila); 2014 Sep; 53(10):960-6. PubMed ID: 24982441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical and Legal Aspects of Prescription Stimulant Use by Medical Students.
    Patel N; Sade RM
    J S C Med Assoc; 2015 Jan; 110(4):127-33. PubMed ID: 27141693
    [No Abstract]   [Full Text] [Related]  

  • 11. Adolescent Patient Education Regarding ADHD Stimulant Diversion And Misuse.
    Colaneri N; Keim S; Adesman A
    Patient Educ Couns; 2017 Feb; 100(2):289-296. PubMed ID: 27609322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
    Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
    Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of attention-deficit/hyperactivity disorder by developmental pediatricians in academic centers: A DBPNet study.
    Feldman HM; Blum NJ; Gahman AE; Shults J;
    Acad Pediatr; 2015; 15(3):282-8. PubMed ID: 25441653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M; Rui P; Ashman JJ
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for Acing the Fundamentals and Mitigating Legal and Ethical Consequences of Poor Physician-Patient Communication.
    Brueck M; Salib AM
    AMA J Ethics; 2017 Mar; 19(3):289-295. PubMed ID: 28323610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label use of medicine in pediatrics: focus on gastrointestinal diseases.
    Karesh A; Tomaino J; Mulberg AE
    Curr Opin Pediatr; 2013 Oct; 25(5):612-7. PubMed ID: 23995427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confronting a Crisis: An Open Letter to America's Physicians on the Opioid Epidemic.
    Stack SJ
    S D Med; 2016 Jun; 69(6):286. PubMed ID: 27443116
    [No Abstract]   [Full Text] [Related]  

  • 20. Examining Physician Interactions with Disease Advocacy Organizations.
    Horrow C; Pacyna JE; Cosenza C; Sharp RR
    AJOB Empir Bioeth; 2019; 10(4):222-230. PubMed ID: 31449475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.